连续血液净化对脓毒症患者外周血NLRP3炎症小体及肠道屏障功能的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

黎介寿肠道屏障研究专项基金(LJS2020C1FF09);国家自然科学基金(82160360);新疆维吾尔自治区自然科学基金(2021D01C305);新疆维吾尔自治区科技支疆项目(2021EO2064);新疆医科大学临床医学高峰学科校内配套经费(33-0104006020801)


Effect of continuous blood purification on peripheral blood NLRP3 inflammasome and intestinal barrier function in patients with sepsis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    探讨连续血液净化(CBP)对脓毒症患者外周血核苷酸结合寡聚化受体蛋白3(NLRP3)及肠道屏障功能的影响。方法 选取2019年5月~2021年5月新疆医科大学第一附属医院重症医学中心收治的脓毒症及非脓毒症患者83例。在镇痛、镇静、液体复苏、抗感染等治疗基础上,根据治疗方式不同,分为脓毒症CBP治疗组(n=24)、脓毒症常规治疗组(n=35)、非脓毒症组(n=24例)。收集各组患者在入住ICU后的一般资料、基础疾病、感染部位、炎症因子水平、肌酐、急性胃肠损伤(AGI)评分、APACHEⅡ评分、28 d预后等资料并进行回顾性分析。结果 3组患者的性别、基础疾病、感染部位等比较差异无统计学意义(P>0.05),CBP治疗组患者基线期APACHEⅡ评分高于其余两组(P<0.05)。与上机前相比,脓毒症CBP治疗组在上机3天后的乳酸、血浆尿素氮(BUN)、外周血淋巴细胞中NF-κB p65、Caspase-1、ASC,血清中IL-1β 、IL-18、血清肠型脂肪酸结合蛋白(I-FABP)、AGI评分有显著降低(均P<0.05)。 脓毒症CBP治疗组28 d死亡率为70.83%,明显高于脓毒症常规治疗组(28.57%)及非脓毒症组(16.67%),差异具有统计学意义(P<0.05)。结论 血液净化治疗可减少脓毒症患者外周血淋巴细胞中 NLRP3 炎症小体的活化,继而减少体内炎症因子水平,改善胃肠道屏障功能。

    Abstract:

    To investigate the effect of continuous blood purification on peripheral blood nucleotide-binding oligomerization receptor protein 3 (NLRP3) and intestinal barrier function in patients with sepsis. Methods A total of 83 patients with sepsis and non-sepsis admitted to the Intensive Care Center of the First Affiliated Hospital of Xinjiang Medical University from May 2019 to May 2021 were selected. On the basis of analgesia, sedation, fluid resuscitation and anti-infection treatment, the patients were divided into CBP group (n=24), conventional treatment group (n=35) and non-sepsis group (n=24) according to different treatment methods. The general data, underlying diseases, infection sites, inflammatory factors, creatinine, AGI score, APACHE Ⅱscore and 28-day prognosis of patients in each group after admission to ICU were collected and analyzed retrospectively. Results There were no significant differences in gender, underlying diseases, and infection sites among the three groups of patients, but the baseline APACHE Ⅱ score of patients in the sepsis CBP treatment group was significantly higher than that of the non-sepsis group and the conventional treatment group. Compared with before the machine, the sepsis CBP group had lactate and plasma/urea nitrogen (BUN) 3 days after the machine was used, peripheral blood lymphocyte NF-κB p65, NLRP3, Caspase-1, ASC; IL-1β in serum, IL-18, I-FABP, AGI score significantly decreased (all P<0.05). The 28-day mortality in the CBP treatment group was 70.83%, which was significantly higher than in the conventional sepsis group (28.57%) and the non-sepsis group (16.67%). Conclusion Blood purification treatment may reduce the activation of NLRP3 inflammasomes in peripheral blood lymphocytes in sepsis patients, and then reduce the level of inflammatory factors in patients with sepsis, and improve the barrier function of the gastrointestinal tract of the patient; but the way through which blood purification improves the barrier function of the gastrointestinal tract still needs further research.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-12-21
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司